Literature DB >> 23018589

Small particle-size talc is associated with poor outcome and increased inflammation in thoracoscopic pleurodesis.

Elena Arellano-Orden1, Auxiliadora Romero-Falcon, José Martin Juan, Manuel Ocaña Jurado, Francisco Rodriguez-Panadero, Ana Montes-Worboys.   

Abstract

RATIONALE: Talc is very effective for pleurodesis, but there is concern about complications, especially acute respiratory distress syndrome.
OBJECTIVES: It was the aim of this study to investigate if talc with a high concentration of small particles induces greater production of cytokines, and if pleural tumor burden has any influence on the local production and spillover of cytokines to the systemic circulation and eventual complications.
METHODS: We investigated 227 consecutive patients with malignant effusion submitted to talc pleurodesis. One hundred and three patients received 'small-particle talc' (ST; containing about 50% particles <10 µm) and 124 received 'large-particle talc' (with <20% particles <10 µm). Serial samples of both pleural fluid and blood were taken before and 3, 24, 48 and 72 h after thoracoscopy. Also, mesothelial cells were stimulated with both types of talc in vitro. MEASUREMENTS AND
RESULTS: Interleukin-8, tumor necrosis factor-α, vascular endothelial growth factor, basic fibroblast growth factor and thrombin-antithrombin complex were measured in all samples. Early death (<7 days after talc) occurred in 8 of 103 patients in the ST and in 1 of 124 in the 'large-particle talc' group (p = 0.007). Patients who received ST had significantly higher proinflammatory cytokines in pleural fluid and serum after talc application, and also in supernatants of the in vitro study. Pleural tumor burden correlated positively with proinflammatory cytokines in serum, suggesting that advanced tumor states induce stronger systemic reactions after talc application.
CONCLUSIONS: ST provokes a strong inflammatory reaction in both pleural space and serum, which is associated with a higher rate of early deaths observed in patients receiving it.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018589     DOI: 10.1159/000342042

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  8 in total

1.  Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer.

Authors:  Juan Chen; Zhu Li; Ning Xu; Xin Zhang; Yu Wang; Dianjie Lin
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leak.

Authors:  Takuya Watanabe; Ichiro Fukai; Katsuhiro Okuda; Satoru Moriyama; Hiroshi Haneda; Osamu Kawano; Keisuke Yokota; Masayuki Shitara; Tsutomu Tatematsu; Tadashi Sakane; Risa Oda; Ryoichi Nakanishi
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

3.  Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion.

Authors:  Youngkyu Moon; Kyung Soo Kim; Jae Kil Park
Journal:  J Cardiothorac Surg       Date:  2015-10-28       Impact factor: 1.637

4.  Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothorax.

Authors:  Kosuke Fujino; Yamato Motooka; Takamasa Koga; Hironobu Osumi; Eri Matsubara; Hidekatsu Shibata; Koei Ikeda; Kenji Shiraishi; Takeshi Mori; Koji Hayashi; Kentaro Yoshimoto; Jyoeji Wakimoto; Ichiro Kubota; Makoto Suzuki
Journal:  Surg Today       Date:  2015-07-24       Impact factor: 2.549

5.  Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial.

Authors:  Warangkana Keeratichananont; Apichat Kaewdech; Suriya Keeratichananont
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

Review 6.  Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis.

Authors:  Wen Zhang; Yun-Long Zhao; Shao-Jun Li; Ying-Nan Zhao; Nan-Nan Guo; Bo Liu
Journal:  J Cardiothorac Surg       Date:  2021-05-04       Impact factor: 1.637

7.  The comparison of pleurodesis effects of iodopovidone at different concentrations and magnesium silicate: An experimental study.

Authors:  Ekin Zorlu; Salih Kür; Zeynep Pekcan; Pınar Atasoy; Nesimi Günal; Koray Dural; Berkant Özpolat
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-10-20       Impact factor: 0.332

8.  Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.

Authors:  Akash Verma; Akhil Chopra; Yeo W Lee; Lavina D Bharwani; Atasha B Asmat; Dokeu B A Aneez; Fazuludeen A Akbar; Albert Y H Lim; Sanjay H Chotirmall; John Abisheganaden
Journal:  Curr Drug Discov Technol       Date:  2016
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.